DB:2FV

Stock Analysis Report

Executive Summary

ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide.

Snowflake

Fundamentals

High growth potential and fair value.

Risks

  • ScandiDos has significant price volatility in the past 3 months.
  • ScandiDos is covered by less than 3 analysts.

Share Price & News

How has ScandiDos's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

7.3%

DB:2FV

-3.4%

DE Medical Equipment

1.8%

DE Market


1 Year Return

-17.5%

DB:2FV

0.2%

DE Medical Equipment

-3.5%

DE Market

2FV underperformed the Medical Equipment industry which returned 0.2% over the past year.

2FV underperformed the Market in Germany which returned -3.5% over the past year.


Share holder returns

2FVIndustryMarket
7 Day7.3%-3.4%1.8%
30 Day1.4%0.8%8.6%
90 Day37.6%-1.2%3.3%
1 Year-13.8%-17.5%1.8%0.2%-0.5%-3.5%
3 Yearn/a102.1%96.8%20.6%10.3%
5 Yearn/a256.2%238.4%30.7%12.8%

Price Volatility Vs. Market

How volatile is ScandiDos's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ScandiDos undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

ScandiDos's share price is below the future cash flow value, and at a moderate discount (> 20%).

ScandiDos's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

ScandiDos is loss making, we can't compare its value to the DE Medical Equipment industry average.

ScandiDos is loss making, we can't compare the value of its earnings to the Germany market.


Price Based on Expected Growth

Unable to calculate PEG ratio for ScandiDos, we can't assess if its growth is good value.


Price Based on Value of Assets

ScandiDos is good value based on assets compared to the DE Medical Equipment industry average.


Next Steps

Future Growth

How is ScandiDos expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

89.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

ScandiDos's revenue is expected to grow by 19.4% yearly, however this is not considered high growth (20% yearly).

ScandiDos's earnings are expected to grow significantly at over 20% yearly.

ScandiDos's revenue growth is expected to exceed the Germany market average.

ScandiDos's earnings growth is expected to exceed the Germany market average.

ScandiDos's earnings growth is expected to exceed the low risk savings rate of 0.2%.


Earnings per Share Growth Estimates


Future Return on Equity

ScandiDos is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has ScandiDos performed over the past 5 years?

-9.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

ScandiDos does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare ScandiDos's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare ScandiDos's 1-year growth to the DE Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if ScandiDos has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if ScandiDos has efficiently used its assets last year compared to the DE Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if ScandiDos improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is ScandiDos's financial position?


Financial Position Analysis

ScandiDos's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

ScandiDos's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

ScandiDos's level of debt (62.3%) compared to net worth is high (greater than 40%).

Unable to establish if ScandiDos's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

ScandiDos has less than a year of cash runway based on current free cash flow.

Unable to confirm if ScandiDos has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is ScandiDos's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate ScandiDos's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate ScandiDos's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as ScandiDos has not reported any payouts.

Unable to verify if ScandiDos's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as ScandiDos has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of ScandiDos's salary, the management and board of directors tenure and is there insider trading?

5.3yrs

Average management tenure


CEO

Görgen Nilsson (59yo)

0yrs

Tenure

kr1,535,000

Compensation

Mr. Görgen Nilsson serves as the Chief Executive Officer of ScandiDos AB (publ) and served as its Member of the Board since 2002 until 2015. 


CEO Compensation Analysis

Görgen's remuneration is lower than average for companies of similar size in Germany.

Görgen's compensation has increased whilst company is loss making.


Management Age and Tenure

5.3yrs

Average Tenure

58yo

Average Age

The average tenure for the ScandiDos management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

4.7yrs

Average Tenure

64.5yo

Average Age

The tenure for the ScandiDos board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Peter Reinli (58yo)

    Vice President of Sales

    • Tenure: 0.08yrs
  • Görgen Nilsson (59yo)

    Chief Executive Officer

    • Tenure: 0yrs
    • Compensation: kr1.54m
  • Catarina Arkebäck (57yo)

    Chief Financial Officer

    • Tenure: 7.7yrs
  • Ingemar Wiberg (64yo)

    Deputy CEO & Director

    • Tenure: 4.7yrs
    • Compensation: kr1.13m
  • Anders Adolfson (45yo)

    Marketing Manager

    • Tenure: 2.9yrs

Board Members

  • Yvonne Petersson (65yo)

    Director

    • Tenure: 4.7yrs
    • Compensation: kr100.00k
  • Tom Sundelin

    Director

    • Tenure: 0yrs
  • Olof Sandén (57yo)

    Chairman of the Board

    • Tenure: 4.7yrs
    • Compensation: kr250.00k
  • Ingemar Wiberg (64yo)

    Deputy CEO & Director

    • Tenure: 4.7yrs
    • Compensation: kr1.13m
  • Björn Zackrisson (65yo)

    Director

    • Tenure: 4.7yrs
    • Compensation: kr100.00k

Company Information

ScandiDos AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ScandiDos AB (publ)
  • Ticker: 2FV
  • Exchange: DB
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr171.847m
  • Listing Market Cap: kr16.156m
  • Shares outstanding: 41.46m
  • Website: https://scandidos.com

Location

  • ScandiDos AB (publ)
  • Uppsala Science Park
  • Uppsala
  • 751 83
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SDOSOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKApr 2014
2FVDB (Deutsche Boerse AG)YesShare CapitalDEEURApr 2014

Biography

ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family soluti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/14 21:57
End of Day Share Price2019/09/13 00:00
Earnings2019/04/30
Annual Earnings2019/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.